Belgium vs Low & middle income: Immunization, HepB3
Belgium
97.0%
in 2024
Low & middle income
83.6%
in 2024
Belgium rank
26th
Low & middle income rank
29th
Immunization, HepB3 over time
- Belgium
- Low & middle income
How they compare
Belgium currently reports 97.0% against 83.6% in Low & middle income, a difference of 13.4%.
That makes Belgium's figure about 1.2 times Low & middle income's.
The two have swapped places 1 time across 28 shared years of data; in 1997 it was Low & middle income ahead.
Belgium ranks 26th and Low & middle income ranks 29th of 188 countries.
Belgium has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Belgium | Low & middle income | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 26.3% | 11.7% | 14.6% | Belgium |
| 2000s | 76.8% | 48.6% | 28.2% | Belgium |
| 2010s | 97.4% | 80.8% | 16.6% | Belgium |
| 2020s | 97.0% | 82.8% | 14.2% | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, Belgium or Low & middle income?
- Belgium, at 97.0% against 83.6% in Low & middle income as of 2024.
- What is the difference in immunization, hepb3 between Belgium and Low & middle income?
- 13.4%, with Belgium ahead.
- How many years of comparable data are there for Belgium and Low & middle income?
- 28 years are reported by both, from 1997 to 2024.
- How do Belgium and Low & middle income rank globally for immunization, hepb3?
- Belgium ranks 26th and Low & middle income ranks 29th of 188 countries.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.